About 3 results found for searched term "ML264" (0.138 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M8650 | ML264 | KLF |
| CID-51003603 | ||
| ML264 is a potent and selective inhibitor of Kruppel-like factor 5 (KLF5) expression. | ||
| M24707 | Indusatumab vedotin | Drug-Linker Conjugates for ADC |
| MLN0264; TAK-264 | ||
| Indusatumab vedotin (MLN-0264; AKT-264) is an antibody-drug conjugate (ADC) consisting of the human anti-guanylate cyclase C (GCC) antibody linked to a microtubule-disruptor Monomethyl auristatin . Indusatumab vedotin has anti-proliferative effects on pancreas cancer cell lines. Indusatumab vedotin arrests cell cycle at G2/M phase, and induces apoptosis. | ||
| M59390 | (E)-N-(p-Amylcinnamoyl)anthranilic acid | TRP Channel |
| (E)-ACA; BML264 | ||
| N-(p-Amylcinnamoyl)anthranilic acid is a broad spectrum PLA2 inhibitor and TRP channel blocker. N-(p-Amylcinnamoyl)anthranilic acid (ACA) functions as a broad spectrum phospholipase A2 inhibitor and blocks transient receptor potential (TRP) channels. It inhibits calcium activated chloride current in cardiac ventricular myocytes. N-(p-Amylcinnamoyl)anthranilic acid has been used as a transient receptor potential cation channel subfamily M member 2 (TRPM2) inhibitor, in studying its role in regulating the production of reactive oxygen species (ROS). | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.
